riskms/iStock via Getty Images
An expert panel of the EU drug regulator, the European Medicines Agency (EMA), endorsed seven new medicines for approval this week, including a cancer drug from ImmunityBio (IBRX), a high-dose version of Novo’s (NVO) obesity drug, Wegovy, and Moderna’s (